Publications

This communique provides an update on the National Clinical Quality Registry Program in September 2025. It covers upcoming funding opportunities and other news and events.

This dashboard provides users with high level information on care minutes in residential aged care.

We’re transferring some referrals for aged care assessment to assessment organisations with capacity to take on additional assessments at this time. Find our more in our frequently asked questions.

The Bilateral Regional Health Forum met on 3 October 2023 to discuss joint interests in rural and regional mental health and suicide prevention, aged care, innovative workforce models, and virtual care in NSW.

This document outlines the terms of reference for the Bilateral Regional Health Forum.

The Modified Monash (MM) fact sheet for category MM 1 covers metropolitan areas.

The Modified Monash (MM) fact sheet for category MM 3 covers rural towns.

A summary of the Aged Care Transition Taskforce meeting held on 24 September 2025.

The Modified Monash (MM) fact sheet for category MM 7 covers very remote communities.

The Modified Monash (MM) fact sheet for category MM 4 covers medium rural towns.

The Modified Monash (MM) fact sheet for category MM 5 covers small rural towns.

The Modified Monash (MM) fact sheet for category MM 6 covers remote communities.

The Modified Monash (MM) fact sheet for category MM 2 covers regional areas.

The Star Ratings Provider Manual contains detailed information about Star Ratings design, calculation and reporting requirements.

This chart shows the structure of the Department of Health, Disability and Ageing including our divisions, branches, statutory office holders and high priority taskforces.

This schedule applies to people receiving care through the Support at Home program from 1 November 2025.

This fact sheet provides information about what NBS expansion means for families and consumers, expansion progress to date, and upcoming milestones.

A template to assist in-home aged care providers on service agreements for the Support at Home program.

Life Saving Drugs Program (LSDP) Expert Panel (the panel) agenda for the 22nd meeting on 31 October 2025.

This fact sheet provides information for providers of non-specialised homes in metropolitan areas on upcoming changes to care minutes funding.

This communique is published following each meeting of the Thriving Kids Advisory Group. It summarises the meeting discussions and outcomes.

These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for acid sphingomyelinase deficiency (ASMD) types A/B and B under the Life Saving Drugs Program.

Treating physicians use this application form to apply for a patient to access LSDP medication for ASMD types A/B and B for the first time, or after a break.

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for ASMD types A/B and B.

Specialists use this spreadsheet to report their patient's test results when reapplying for treatment under the Life Saving Drugs Program.